Can Taking Mounjaro Cause Diabetes?

Does Mounjaro raise the risk of developing diabetes?

The short answer is no, and the mechanism explains why. Tirzepatide works by stimulating two gut-hormone receptors simultaneously (GIP and GLP-1) that are both involved in how the body manages blood sugar after meals. Activating these receptors improves the pancreas's insulin response and increases the body's sensitivity to insulin. The NHS page on tirzepatide describes this dual action clearly, and the NHS medicines information for tirzepatide confirms it is used to treat type 2 diabetes as well as manage weight.

In the SURMOUNT-1 trial, which enrolled thousands of adults without diabetes, there was no signal that tirzepatide triggered new-onset diabetes. On the contrary, participants who had prediabetes at the start of the study showed improvements in blood-glucose markers over 72 weeks. That evidence informed NICE's appraisal of tirzepatide (TA1026), which recommended it as a weight-management treatment for eligible adults.

The confusion sometimes arises because people hear "it affects insulin" and assume something risky is happening. The direction of effect is the opposite of what causes type 2 diabetes. Mounjaro does not suppress insulin production; it supports a more appropriate release of it in response to food. If you're curious about whether Mounjaro can cause diabetes, our page exploring that question in detail covers the mechanism in more depth.

Can Mounjaro cause low blood sugar, and is that the same as getting diabetes?

Hypoglycaemia (blood sugar falling too low) is a different concern from developing diabetes, and the distinction matters. In people taking Mounjaro for weight loss alone, hypoglycaemia is uncommon. The risk rises if Mounjaro is used alongside other glucose-lowering medicines, particularly sulphonylureas or insulin, because the combined effect can push blood sugar down further than intended. That is a dosing and drug-interaction issue, not the medicine creating a new disease.

If you are already taking medication for type 2 diabetes and your prescriber adds Mounjaro, a dose review of your existing diabetes treatment is typically part of the clinical plan. Our page on how Mounjaro relates to diabetes sets out how that usually works in practice. The prescriber (not the patient) adjusts those doses; personal changes to timing or amounts should never be made without professional input.

The NHS notes that symptoms such as shaking, sweating, confusion or sudden hunger while on a GLP-1 medicine alongside other diabetes treatments warrant prompt attention. If any of those occur, the right step is to contact your prescriber the same day, or 111 if you cannot reach them.

Who should be especially careful, and what to tell your prescriber?

A few groups need an honest conversation before starting, not because Mounjaro causes diabetes but because the interaction between the medicine and their existing health picture is more complex. Anyone with prediabetes should tell their prescriber, because Mounjaro often improves those markers, but monitoring is still sensible. People already on insulin or sulphonylureas need a prescriber to plan carefully for hypoglycaemia risk before the first pen is used.

A history of pancreatitis is a separate but relevant flag. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines; severe stomach pain radiating to the back warrants urgent medical attention. That update is available via the MHRA's Yellow Card reporting portal, where patients can also flag any suspected side effects of their own.

If you have a family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, that is a contraindication to tirzepatide regardless of any diabetes question. Pregnancy, breastfeeding, and actively trying to conceive are all situations in which Mounjaro is not recommended; speak to your GP or specialist for guidance specific to your circumstances. For the full picture of what Mounjaro involves, our Mounjaro overview is a good starting point, and our clinical team is available to answer questions via aftercare seven days a week.

How does the clinical review at nume address this question?

Before any prescription is written, a GPhC-registered Independent Prescriber reads your consultation personally, your medical history, current medications, and any conditions including diabetes or blood-glucose concerns. That review happens the same day as your consultation, which matters if you've been researching this at nine in the morning and want clarity before the afternoon.

Transfer patients coming from another provider, or those requesting a dose increase, provide evidence of their current treatment as part of our process. That is not bureaucracy; it is how responsible prescribing works for a medicine that interacts with blood-sugar physiology. If your history makes Mounjaro unsuitable, you'll be told clearly and honestly, not signed up anyway.

To understand how weight-loss treatment at nume works, the treatment overview page explains the full process from consultation to delivery. If you're still weighing up which treatment might suit your situation, the weight-loss treatment guide covers the options. And if you have alcohol use or other lifestyle questions alongside diabetes concerns, our guide on drinking while taking Mounjaro addresses the interaction evidence specifically. Ready to get a clear clinical answer for your situation? Speak to our prescribers through a free consultation.